Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy

Did smokers do better than non-smokers in a clinical trial for an experimental cancer treatment? That was the intriguing question that led University of Iowa researchers and their colleagues to develop a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells.

A novel approach for lymph node metastasis treatment

Researchers at Tohoku University have discovered a new approach for treating lymph node metastasis. Anticancer drugs are administered directly into the LNs under ultrasound guidance (lymphatic drug delivery system or LDDS) to target sentinel lymph nodes (LNs) and generate antitumor effects locally, preventing distant metastasis. This approach not only improves the anticancer effect but also reduces the nasty side effects commonly associated with systemic chemotherapy.

Researchers identify diverse neuron types associated with vulnerability to Parkinson’s disease

Through transcriptomic profiling of more than 300,000 cells in human substantia nigra, a part of the brain that helps control the body’s movements, a research team has identified a previously unreported neuron type with vulnerability in Parkinson’s disease. This novel finding could help explain the complexity of the disease symptoms and direct new therapeutics development.